Roche's Astegolimab for COPD: Mixed Trial Results in Intensifying Biologics Race

Chronic Obstructive Pulmonary Disease (COPD) is a serious and widespread lung condition that ranks as the third leading cause of death worldwide. It significantly impacts patients' quality of life, often leading to shortness of breath, coughing, and frequent flare-ups, known as exacerbations